These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 18612551

  • 1. Treatment of acquired thrombotic thrombocytopenic purpura (TTP) with plasma infusion plus rituximab.
    Hagel S, Jantsch J, Budde U, Kalden JR, Eckardt KU, Veelken R.
    Thromb Haemost; 2008 Jul; 100(1):151-3. PubMed ID: 18612551
    [No Abstract] [Full Text] [Related]

  • 2. Rituximab as preventive therapy of a clinical relapse in TTP with ADAMTS13 inhibitor.
    Schleinitz N, Ebbo M, Mazodier K, Poullin P, Bernit E, Veit V, Veyradier A, Fakhouri F, Kaplanski G, Harle JR.
    Am J Hematol; 2007 May; 82(5):417-8. PubMed ID: 17266057
    [No Abstract] [Full Text] [Related]

  • 3. Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13.
    Scully M, Cohen H, Cavenagh J, Benjamin S, Starke R, Killick S, Mackie I, Machin SJ.
    Br J Haematol; 2007 Feb; 136(3):451-61. PubMed ID: 17233847
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of rituximab and concurrent plasma exchange in the treatment of thrombotic thrombocytopenic purpura.
    Hull MJ, Eichbaum QG.
    Clin Adv Hematol Oncol; 2006 Mar; 4(3):210-4; discussion 217-8. PubMed ID: 16728930
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Current insight into thrombotic thrombocytopenic purpura.
    Verbeke L, Delforge M, Dierickx D.
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):3-10. PubMed ID: 19851089
    [Abstract] [Full Text] [Related]

  • 8. Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab.
    Zheng X, Pallera AM, Goodnough LT, Sadler JE, Blinder MA.
    Ann Intern Med; 2003 Jan 21; 138(2):105-8. PubMed ID: 12529092
    [Abstract] [Full Text] [Related]

  • 9. Thrombotic thrombocytopenic purpura: from the bench to the bedside, but not yet to the community.
    George JN, Vesely SK.
    Ann Intern Med; 2003 Jan 21; 138(2):152-3. PubMed ID: 12529099
    [No Abstract] [Full Text] [Related]

  • 10. Summaries for patients. Treatment of refractory thrombotic thrombocytopenic purpura.
    Ann Intern Med; 2003 Jan 21; 138(2):I38. PubMed ID: 12529111
    [No Abstract] [Full Text] [Related]

  • 11. Rituximab and intermediate-purity plasma-derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitor.
    Pandey S, Nakagawa M, Rosenbaum ER, Arnaoutakis K, Hutchins LF, Makhoul I, Milojkovic N, Cottler-Fox M.
    J Clin Apher; 2015 Feb 21; 30(1):50-4. PubMed ID: 25042026
    [Abstract] [Full Text] [Related]

  • 12. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
    Sadler JE.
    Blood; 2008 Jul 01; 112(1):11-8. PubMed ID: 18574040
    [Abstract] [Full Text] [Related]

  • 13. Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP).
    Ahmad A, Aggarwal A, Sharma D, Dave HP, Kinsella V, Rick ME, Schechter GP.
    Am J Hematol; 2004 Oct 01; 77(2):171-6. PubMed ID: 15389904
    [Abstract] [Full Text] [Related]

  • 14. Rituximab provided long-term remission in a patient with refractory relapsing thrombotic thrombocytopenic purpura.
    Kosugi S, Matsumoto M, Ohtani Y, Take H, Ishizashi H, Fujimura Y, Kuyama J.
    Int J Hematol; 2005 Jun 01; 81(5):433-6. PubMed ID: 16158827
    [Abstract] [Full Text] [Related]

  • 15. A Canadian phase II study evaluating the efficacy of rituximab in the management of patients with relapsed/refractory thrombotic thrombocytopenic purpura.
    Foley SR, Webert K, Arnold DM, Rock GA, Clark WF, Barth D, Sutton DM, Members of the Canada Apheresis Group (CAG).
    Kidney Int Suppl; 2009 Feb 01; (112):S55-8. PubMed ID: 19180138
    [Abstract] [Full Text] [Related]

  • 16. A 9-month-old infant with acquired idiopathic thrombotic thrombocytopenic purpura caused by inhibitory IgG-autoantibody to ADAMTS13.
    Sato A, Hoshi Y, Onuma M, Sato R, Tsunematsu Y, Isonishi A, Matsumoto M, Fujimura Y, Imaizumi M.
    Pediatr Hematol Oncol; 2010 Feb 01; 27(1):53-8. PubMed ID: 20121555
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Successful treatment of thrombotic thrombocytopenic purpura (TTP) with rituximab].
    Arici B, Trendelenburg M.
    Ther Umsch; 2008 Dec 01; 65(12):710-2. PubMed ID: 19048526
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Relapses of thrombotic thrombocytopenic purpura after treatment with rituximab.
    Goyal J, Adamski J, Lima JL, Marques MB.
    J Clin Apher; 2013 Dec 01; 28(6):390-4. PubMed ID: 23857472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.